Intradural Spinal Seeding and Fatal Progression of a Sacrococcygeal Chordoma: a Case Report
Ji Tao,Guo Wei,Shen Dan-Hua,Yang Yi,Tang Shun
DOI: https://doi.org/10.1097/00029330-200806020-00025
2008-01-01
Abstract:Chordoma as a rare malignant tumor arising from remnants of the fetal notochord accounts for 1%-4% of primary bone tumors. It is usually predominant in males. Local recurrences are common (44%-78%)1-3 and distant metastases may occur years after the initial presentation. The reported rates of metastases range from 10% to 48%,4-6 which are usually accompanied by a sacrococcygeal chordoma. Cases of surgical seeding and intradural spinal seeding also have been reported clinically.7-9 To our knowledge, the present case is the first one concerning cerebrospinal fluid metastases and fatal progression of a sacrococcygeal chordoma. CASE REPORT A 51-year-old man complaining of sacral pain as well as bowel and bladder incontinence for one year was admitted to our hospital in May 2001, and a sacral chordoma was diagnosed. Pelvic computed tomography (CT) showed a tumor of 8 cm in diameter extending anteriorly from the sacrum (Figure 1A). He underwent subtotal sacretomy including resection of the sacrum up to the S1 level via a posterior surgical approach with preservation of bilateral S3 roots. Cerebrospinal fluid leakage occurred during the operation because of a tear in the dura. Histologically, a typical chordoma was diagnosed. Radiation was given to the patient postoperatively (total 50 Gy). Follow-up by imaging showed no evidence of local recurrence and metastases.Figure 1. (A): Preoperative axial computed tomography image shows a tumor extending anterior from the sacrum with the diameter of 8 cm. (B) The pelvic axial MRI shows the sacral chordoma being controlled without local recurrence two years after initial surgery.Two years later in July 2003, he complained of lower back pain and weakness of bilateral lower extremities for two months; again he was hospitalized for further evaluation. The sacral chordoma was locally well-controlled (Figure 1B). Magnetic resonance imaging (MRI) showed multiple intradural metastatic lesions at the lumbar spine (Figure 2). The lesions at the L2-3 and L3-4 levels which compressed the spinal cord were totally removed by laminectomy. They were diagnosed pathologically as intradural spinal seeding of the sacral chordoma. Immunohistochemically, the tumor cells were positive for epithelial membrane antigen (EMA), S-100 protein and cytokeratin (CK).Figure 2.: A sagittal spinal MRI scan shows two intradural seeding lesions at lumbar vertebral level.Three years later, approximately 5 years from the initial surgical treatment, the patient complained of recurrence of back pain and left lower extremity pain with hyperesthesia. MRI showed a metastatic soft tissue mass localized at the T12-L1 intervertebral foramina and paravertebra (Figure 3A and 3B). Extensive search for metastasis showed nothing. During surgical resection and pedicle screw fixation of T11 and L2 vertebrae bilaterally, a tumor that was tightly attached to the nerve root was observed. That was diagnosed as a metastatic chordoma in the T12 and L1 vertebrae histopathologically (Figure 4).Figure 3.: MRI sagittal (A) and axial (B) sections show paravertebral lesion at T12/L1 intervertebral foramina level, and a metastatic chordoma was proved bioptically. (C) A circled paravertebral tumorous destruction at T4 level on an axial CT image. (D) An abdominal CT scan reveals an asymptomatic lesion in liver. A needle biopsy of this lesion confirmed the suspicion of metastatic chordoma.Figure 4. (A): Tumor cells arranged in cords and typical vacuolated “physaliferous” cells can be seen in intradural lesions (HE, original magnification ×100). (B) The vertebra was infiltrated by sheets of pleomorphic cells with oval-shaped nuclei and fibrillar eosinophilic cytoplasm (HE, original magnification ×40). (C) Representative area of T12/L1 paravertebral metastasis, showing pleomorphism, hemorrhage and necrosis without dedifferentiation (HE, original magnification ×100). (D) Liver tumor needle biopsy histopathologic findings showing the typical apearance of chordoma. It ranged in cells lobules separated by a little of mucoid intercellular tissue (HE, original magnification ×100).Three months after the operation, a CT examination for recurrent back pain revealed multiple metastases in the T3-5 vertebrae and left paravertebrae including metastases of adjacent ribs in addition to a large liver metastatic mass with a diameter of 10 cm (Figure 3C and 3D). The lesions were confirmed by needle biopsies as the metastasis of chordoma (Figure 4). The patient received the fourth operation for metastases to the thoracic vertebra and rib. Tumor resection and fixation with pedicle screws were performed through a posterior approach for prophylaxis of underlying vertebrae compression fracture. Since the resection of liver metastasis was impossible, palliative treatment by radio-frequency ablation (RFA) was prescribed. Unfortunately, widespread metastases including intrahepatic metastases and omentum (Figure 5) were detected by abdominal CT scan four months after RFA therapy. By laparotomy, however, extremely extensive dissemination of tumor cells was found. There were widespread implantation metastases to the surface of the stomach, duodenum, small bowel, colon and rectum, and also to the omentum. Palliative omentectomy was done. Histopathologically, a metastatic chordoma was diagnosed and the Ki-67 labeling index was 20%. By request of the patient, no additional treatment was given. At the time of writing this report, he is moribund.Figure 5. (A): CT scan shows rapid progression of liver metastatic lesions. Multiple nodules (white arrows) can be seen around the initial lesion. (B) Abdominal CT scan shows multiple metastatic nodules on the omentum (white arrow).DISCUSSION Few cases of intradural spinal seeding from a sacrococcygeal chordoma have been reported in contrast to cases of intradural spinal seeding from clival chordoma.8 Intradural spinal seeding from clival chordoma and sacrococcygeal chordoma attributs to cerebrospinal fluid metastasis. Tumor seeding during surgery is one of the predisposing factors for spinal seeding. Chordoma primarily originates from the sacra and extradural space. It is a general agreement that complete surgical resection with wide tumor-free margins is the treatment of choice for a sacral chordoma.2,10,11 However, ensuring adequate margin may come at the expense of normal adjacent neurovascular structure and associated function. We usually try to preserve the sacral nerve roots because preservation of bilateral S1, S2 roots and at least one S3 root will preserve major functions. Manipulation including separation of the nerve root from the tumor tissue or resection of the neural elements may cause such complications as dura tear and cerebrospinal fluid leakage. Particularly, the dura of the cauda equina is easily injured in surgery for nerve preservation, so tumor cells can directly penetrate into the cerebrospinal fluid circulation and encase arteries. The time interval from diagnosis of skull base chordoma to spinal seeding ranges from seven months to five years.8 In our case the interval was 26 months from the initial surgical treatment. The incidence of chordoma metastases is between 10% and 48%. Chambers and Schwinn4 found that pulmonary (58%) and lymph node metastases (33%) are more frequent than liver (22%) and bone metastases (17%). Skin metastases have a frequency of 6.3%-10%.12 The mean interval from primary surgery to metastases, however, varies widely from 36 to 72 months.3,4,13 The metastasis rate of primary sacrococcygeal chordomas ranges from 30% to 50%, that is higher than the expected.2,13 The sites of metastatic primary tumors are predominantly sacral and vertebral. Metastases are more frequently associated with primary localized vertebral chordoma than with sacrococcygeal chordoma.4,6 Higinbotham et al6 found 5 cases (10.9%) of liver metastasis in 46 cases of chordoma. Bergh et al13 reported that the mean interval from primary surgery to metastasis was 6 years in patients with lumbosacral chordoma and that the survival time of the patients after detection of metastasis was very short (mean 0.2 year). Thirty-four months after intradural spinal seeding, systemic widespread metastases occurred. The present case was the only one with liver metastasis in 47 consecutive cases of sacrococcygeal chordoma during the period of 1996-2005 at the authors' institution. Another major problem in the treatment of this case is the use of percutaneous RFA for liver metastasis of a sacrococcygeal chordoma. We attribute implantation metastases of abdominal viscera surface to RFA, by which tumor cells metastasize to the omentum and visceral organs. The propensity for chordoma seeding has been confirmed,7 but recurrence after surgery has been rarely described. Arnautovic et al7 reported a rate of 7.3% for surgical seeding of chordoma. They also found that 5 to 15 months (mean 12 months) are necessary between the time of surgery when seeding occurs and the actual growth of a symptomatic mass. As RFA is performed by passing a large electrode needle through the abdominal wall and liver tissue to the target lesions, tumor seeding along the needle track is considered as a late complication.13 Secondary intrahepatic spread of hepatic cell carcinoma treated by RFA has been reported.14,15 In our case, the possible “intrahepatic seeding” was suggested by imaging follow-up showing new intrahepatic chordoma nodules located around the earliest metastatic lesion. Although RFA therapy is a promising option in palliative treatment of unresectable liver tumors, rare complications have to be considered. In our case, we could not distinguish between the two possible mechanisms of either surgical implantation of tumor cells at the time of percutaneous RFA or systemic, lymphatic or hematogenous spread to this particular location. Therefore particular attention should be paid to RFA therapy for liver metastases of chordoma.